Dendritic-Cell (DC) Targeting Universal Vaccine for Influenza Infection
A novel DC-targeting vaccine platform using Ebola glycoprotein (EboGP) DC-targeting domain-based fusion protein technology
Published: 1st June 2022

Patents
- PCT/CA2020/0151409
IP Status
- Patented
Seeking
- Development partner
- Commercial partner
- Licensing